Hipercalcemias das Neoplasias Malignas
DOI:
https://doi.org/10.32635/2176-9745.RBC.1982v29n2.3530Keywords:
Neoplasms/complications, HypercalcemiaAbstract
The authors have revised the physiopathological mechanisms of hypercalcemia in malignat diseases. They also present the clinical aspects and differential diagnosis, as well as the different treatments available in such cases. The study of one clinical case is added as an example of steps of treatment mentioned. In the text.
Downloads
References
ALBRIGHT, F. — Cited in case Records of the Massachussets General Hospital; Case 27461. N. Engl. J. Med., 225: 789-791, 1941. DOI: https://doi.org/10.1056/NEJM194111132252007
ALBRIGHT, F.; BAUER, W,; CLAFLIN, O. et al. — Studies in parathyroid physiology III. The effect of phosphate ingestion in clinical hyperparathyroidism. J. Clin. invest., II: 411-435, 1953. DOI: https://doi.org/10.1172/JCI100423
BECKER, V.L., — Hypercalcemia associated with estrogen administration in patients with breast carcinoma. Cancer, 24: 610-616, 1969. DOI: https://doi.org/10.1002/1097-0142(196909)24:3<610::AID-CNCR2820240328>3.0.CO;2-4
BINSTOCK, M.L.; MUNDY, G.R. — Effect of calcitonin and glucocorticoids in combination on the hypercalcemia Of malignancy. Ann. intern. Med., 93: 269-272, 1980. DOI: https://doi.org/10.7326/0003-4819-93-2-269
BRERETON, H.D.; HALUSHKA, P.V.; ALEXANDRE, R.W. et al. - Indomethacin-responsive hypercalcemia in a patient with renal cell adenocarcinoma. N. Engl. J. Med., 291'.83-85, 1974. DOI: https://doi.org/10.1056/NEJM197407112910207
BREWER, H.B. - Osteoclastic Bone Resorption and the hypercalcemia of cancer. N. Engi. J. Med., 291: 1081-1082, 1974. DOI: https://doi.org/10.1056/NEJM197411142912009
DEFTOS, L.J.; FIRST, B.P. - Calcitonin as a drug. Ann Intern. Med., 95: 192-197, 1981. DOI: https://doi.org/10.7326/0003-4819-95-2-192
EILON, G.; MUNDY, G.R.-Direct resorption of bone by human breast câncer cells in vitro. Nature, 276: 726-728, 1978. DOI: https://doi.org/10.1038/276726a0
FAN, H.W., FAHEY, T.J.; NASH, A.G. et al. — Primary hyperparathyroidism and câncer. Am. J. Surg., 126: 539-543, 1973. DOI: https://doi.org/10.1016/S0002-9610(73)80046-7
GOLDSMITH, R.S. - Treatment of hypercalcemia. Med. Clin. of North America, 56: 951 -960, 1972. DOI: https://doi.org/10.1016/S0025-7125(16)32361-6
GOLDSMITH, R.S.; - INGBAR, S. H. — Inorganic Phosphatetreatment of hypercalcemia of diverse etiologies. N. Engi. J. Med., 274: 1-7, 1966. DOI: https://doi.org/10.1056/NEJM196601062740101
HICKEY, R.C.; SAMAAN, N.A.; JACKSON, G.L. — Hypercalcemia in patients with breast cancer. Arch Surg, 116: 545-552, 1981. DOI: https://doi.org/10.1001/archsurg.1981.01380170035006
HIRSHORN, J.E.; VRHOUSEK, E.; POSEN, S. — Carcinoma of the breast associated with hypercalcemia and the presence of parathyrold hormone-like substance in the tumor. J. Clin. Cndocrinol. Metab., 48: 217-221, 1979. DOI: https://doi.org/10.1210/jcem-48-2-217
HORTON, J.E. et al. — Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science, 177: 793-795, 1972. DOI: https://doi.org/10.1126/science.177.4051.793
JACOBS, T.P.; SIRIS, E.S.; BILEZIKIAN, J.P. et al. — Hypercalcemia of malignancy: Treatment with intravenous dichioromethylene diphosphonate. Ann. intern. Med.,94: 312-316, 1981. DOI: https://doi.org/10.7326/0003-4819-94-3-312
KAPLAN, L; KATZ, A.D.; BEN, I.C. et al. — Malignat neoplasms and paratyroid adenoma. Cancer, 28: 401-407,1971. DOI: https://doi.org/10.1002/1097-0142(197108)28:2<401::AID-CNCR2820280221>3.0.CO;2-H
KENNEDY, B.J.; TIBBETS, D.M.; NATHANSON, I.T. et al. - Hypercalcemia, a complication of hormona therapy of advanced breast cancer. Cancer Res., 13: 445, 1953.
LAFFERTY, F.W. — Pseudohyperparathyroidsm. Medicine 45- 247-260, 1966. DOI: https://doi.org/10.1097/00005792-196605000-00004
LENTZ, R.D., BROWN, D.M.; KJELLSTRAND, C.M. – Treatment of Severe hypophosphatemía. Ann. intern. Med., 89: 941 -944, 1978. DOI: https://doi.org/10.7326/0003-4819-89-6-941
LEVINE, L.; HINKLE, P.M.; VOELKEL, E.F. et al. — Prostaglandin production by mouse fibrosarcoma cells in tissue culture: inhibition by indomethacin and aspirín. Bioch. Biophys Res. Commun., 47: 888-896, 1972. DOI: https://doi.org/10.1016/0006-291X(72)90576-1
MAVLIGIT, G.M.; COHEN, J.L.; SHERWOOD, L.M. Ectoplc production of paratyroid hormone and carcinoma of the breast. N. Engl. J. Med., 285: 154-156, 1971. DOI: https://doi.org/10.1056/NEJM197107152850307
MUGGIA, F.M.; HEINEMANN, H. C. - Hypercalcemia associated with Neoplastic Disease. Ann. intern. Med., 73, 2: 281-290, 1970. DOI: https://doi.org/10.7326/0003-4819-73-2-281
MUNDY, G.R.; RAISZ, L.G.; COOPER, R.A. et al. — Evidence for the secretion of an osteoclast stimulating factor in myeloma. N. Engl. J. Med., 291: 1041-1046, 1974. DOI: https://doi.org/10.1056/NEJM197411142912001
POWELL, D.; SINGER, F.R.; MURRAY, T.M. et al.: — Nonparathyroyd humoral hypercalcemia in patients with neoplastic diseases. N. Engl. J. Med. 289: 176-181, 1973. DOI: https://doi.org/10.1056/NEJM197307262890403
RAISZ, L.G. — Prostaglandins and the Hypercalcemia of cancer. N Engl. J. Med., 289: 214-215, 1973. DOI: https://doi.org/10.1056/NEJM197307262890412
RAISZ, L.G.; YAJNIK, C.H.; BOKMAN, R.S. et al. — Comparison of comercially Available Parathyroid Hormone Immunoassays in the differencial diagnosis of hypercalcemia dueto primary hyperparathyroidism or malignancy. Ann. intern. Med., 91: 739-740, 1979. DOI: https://doi.org/10.7326/0003-4819-91-5-739
SCHNEIDER, A.B.; SHERWOOD, L.M. — Calcium homeostasis and the pathogenesis and management of hypercalcemic disorders. Metabolism, 29: 975-1007, 1974. DOI: https://doi.org/10.1016/0026-0495(74)90046-8
SCHOLTZ, D.A.; PURNELL, D.C; GOLDSMITH, R.S. et al. — Diagnostic considerations in hypercalcemic Syndromes. Med. Clin. of North America, 56: 941-950, 1972. DOI: https://doi.org/10.1016/S0025-7125(16)32360-4
SEYBERTH, H.W.; SEGRE, G.V.; MORGAN, J. L. et al. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N. Engl. J. Med., 293: 1278-1283, 1975. DOI: https://doi.org/10.1056/NEJM197512182932502
SHERWOOD, L.M. - Ectopic hormone syndromes. In: Ingbar S.M., ed contemporary endocrinology Vol. I New York. Plenum Press, 341-386, 1979. DOI: https://doi.org/10.1007/978-1-4757-4857-4_10
SHERWOOD, L.M. - The Multiple causes of hypercalcemia in malignant disease. N. Engl. J. Med 303: 1412-1413, 1980. DOI: https://doi.org/10.1056/NEJM198012113032409
STEWART, A.F.; HORTS, R.; DEFTOS, L.J. et al. — Biochemical evaluation of patients with cancer — Associated hypercalcemia: Evidence for humoral and nonhumoral groups. N. Engl. J. Med., 303: 1377- 1383, 1980. DOI: https://doi.org/10.1056/NEJM198012113032401
SUKI, W.N.; YIUM, J.J.; VON MINDEN, M. et al. — Acute Treatment of hypercalcemia with furosemida. N. Engl. J. Med., 283: 836-840, 1970. DOI: https://doi.org/10.1056/NEJM197010152831603
TASHJIAN Jr. A. H.; VOELKEL E.F.; GOLDHABER, P. et al. - Successfull treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrossarcoma. Prostaglandins, 3: 515-524, 1973. DOI: https://doi.org/10.1016/0090-6980(73)90161-5
TASHJIAN Jr., A.H. — Tumor Humors and the hypercalcemias of cancer. N. Engl. J. Med., 290: 905-906, 1974. DOI: https://doi.org/10.1056/NEJM197404182901611
TASHJIAN Jr. A. H. — Prostaglandins, hypercalcemia and cancer. N. Engl.. J. Med., 293: 1317-1318, 1975. DOI: https://doi.org/10.1056/NEJM197512182932511
TASHJIAN, Jr., A.H. Role of prostaglandins in the production of hypercalcemia by tumors. Cancer Res.. 38: 4139-4141, 1978.
